Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration    crawled time : 12:02    save search
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
Published: 2020-12-08 (Crawled : 12:02) - globenewswire.com
BMY | $48.72 -0.55% 250K twitter stocktwits trandingview |
Health Technology
 | | O: -0.05% H: 1.0% C: -0.08%
CMPI | $10.5 0.0% twitter stocktwits trandingview |
Health Technology
 | | O: 2.49% H: 10.34% C: 10.34%
collaboration nivolumab
Gainers vs Losers
71% 29%

Top 10 Gainers
CZOO | $9.98 100.0% 330K twitter stocktwits trandingview |

AMST | $3.48 74.0% 21M twitter stocktwits trandingview |
Technology Services
BOF | $1.78 52.14% 15M twitter stocktwits trandingview |

CSSE 4 | $0.2184 43.4% 36M twitter stocktwits trandingview |
Consumer Services
ACB | $7.32 16.56% 780K twitter stocktwits trandingview |
Process Industries
AEYE | $15.42 14.39% 150K twitter stocktwits trandingview |
Technology Services
BACK | $3.75 13.64% 44K twitter stocktwits trandingview |
Health Care and Social Assistan...
CGC | $8.835 12.55% 740K twitter stocktwits trandingview |
Process Industries
BW | News | $1.0002 9.05% 190K twitter stocktwits trandingview |
Electronic Technology
BILI | $12.525 9.01% 3.5M twitter stocktwits trandingview |
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.